<VariationArchive RecordType="classified" VariationID="831758" VariationName="NC_000017.11:g.(?_42900800)_(42904229_?)del" VariationType="Deletion" Accession="VCV000831758" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="821044" VariationID="831758">
      <GeneList>
        <Gene Symbol="G6PC1" FullName="glucose-6-phosphatase catalytic subunit 1" GeneID="2538" HGNC_ID="HGNC:4056" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42900799" stop="42914438" display_start="42900799" display_stop="42914438" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="41052813" stop="41066449" display_start="41052813" display_stop="41066449" Strand="+" />
          </Location>
          <OMIM>613742</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000017.11:g.(?_42900800)_(42904229_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" innerStart="41052817" innerStop="41056246" display_start="41052817" display_stop="41056246" variantLength="3430" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.(?_41052817)_(41056246_?)del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.(?_41052817)_(41056246_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000017.11:g.(?_42900800)_(42904229_?)del AND Glycogen storage disease due to glucose-6-phosphatase deficiency type IA" Accession="RCV001032296" Version="1">
        <ClassifiedConditionList TraitSetID="3246">
          <ClassifiedCondition DB="MedGen" ID="C2919796">Glycogen storage disease due to glucose-6-phosphatase deficiency type IA</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-06-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30279644</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3246" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10924" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD Ia</ElementValue>
                <XRef Type="MIM" ID="232200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease due to glucose-6-phosphatase deficiency type IA</ElementValue>
                <XRef ID="MONDO:0009287" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 1A</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+1A/3120" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Gierke disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatorenal form of glycogen storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose-6-phosphatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatorenal glycogenosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose-6-phosphatase deficiency glycogen storage disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GSD1</ElementValue>
                <XRef Type="MIM" ID="232200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">GSD1A</ElementValue>
                <XRef Type="MIM" ID="232200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7864" />
                <XRef ID="7864" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type I (GSDI) is characterized by accumulation of glycogen and fat in the liver and kidneys resulting in hepatomegaly and nephromegaly. Severely affected infants present in the neonatal period with severe hypoglycemia due to fasting intolerance. More commonly, untreated infants present at age three to four months with hepatomegaly, severe hypoglycemia with or without seizures, lactic acidosis, hyperuricemia, and hypertriglyceridemia. Affected children typically have doll-like faces with full cheeks, relatively thin extremities, short stature, and a protuberant abdomen. Xanthoma and diarrhea may be present. Impaired platelet function and development of reduced or dysfunctional von Willebrand factor can lead to a bleeding tendency with frequent epistaxis and menorrhagia in females. Individuals with untreated GSDIb are more likely to develop impaired neutrophil and monocyte function as well as chronic neutropenia resulting in recurrent bacterial infections, gingivitis, periodontitis, and genital and intestinal ulcers. Long-term complications of untreated GSDI include short stature, osteoporosis, delayed puberty, renal disease (including proximal and distal renal tubular acidosis, renal stones, and renal failure), gout, systemic hypertension, pulmonary hypertension, hepatic adenomas with potential for malignancy, pancreatitis, and polycystic ovaries. Seizures and cognitive impairment may occur in individuals with prolonged periods of hypoglycemia. Normal growth and puberty are expected in treated children. Most affected individuals live into adulthood.</Attribute>
                <XRef ID="NBK1312" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301489</ID>
                <ID Source="BookShelf">NBK1312</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2014">
                <ID Source="PubMed">25356975</ID>
              </Citation>
              <XRef ID="364" DB="Orphanet" />
              <XRef ID="79258" DB="Orphanet" />
              <XRef ID="C2919796" DB="MedGen" />
              <XRef ID="MONDO:0009287" DB="MONDO" />
              <XRef Type="MIM" ID="232200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2356858" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6097396|MedGen:CN069618" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001195603" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30279644</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 1-2 of the G6PC gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 2 of the G6PC gene. This is expected to result in an absent or disrupted protein product. A similar deletion of exons 1-2 has been reported in an individual affected with glycogen storage disease type Ia (PMID: 30279644). Loss-of-function variants in G6PC are known to be pathogenic (PMID: 8182131). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="G6PC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.(?_41052817)_(41056246_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN069618" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2356858" TraitType="Disease" MappingType="XRef" MappingValue="CN069618" MappingRef="MedGen">
        <MedGen CUI="C2919796" Name="Glycogen storage disease due to glucose-6-phosphatase deficiency type IA" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

